Antibodies in serums from newly diagnosed insulin-dependent (type I) diabetes mellitus (IDDM) patients and individuals experiencing early phases of β-cell destruction specifically immunoprecipitate a minor pancreatic islet cell membrane protein of 64,000 Mr (64K). In this report, we demonstrate the use of two-dimensional (2-D) gel electrophoresis to unambiguously identify the 64K antigen. By nonequilibrium pH-gradient gel electrophoresis in the first dimension and sodium dodecyl sulphate-polyacrylamide gel electrophoresis in the second dimension, the 64K protein separates into two components, designated α and β, that differ in size but display identical charge heterogeneity. The high resolution of the 2-D method efficiently separates the 64K components from background proteins in immunoprecipitates from crude detergent lysates of islets. The background proteins were identified as major cellular proteins carried nonspecifically through the immunoprecipitation procedure. The high affinity and specificity of the 64K autoantibodies were demonstrated by the exclusive and > 1000-fold purification of this minor protein by immunoprecipitation with IDDM serums. The 2-D analyses did not reveal additional proteins specifically immunoprecipitated by IDDM serums, suggesting that the 64K protein is the only protein antigen specifically and consistently recognized by IDDM autoantibodies in the relatively stringent conditions of immunoprecipitation. Moreover, the 2-D analyses demonstrate that purification of membrane protein fractions from both human and rat islets before the immunoprecipitation efficiently removes background proteins and substantially increases the specificity of 64K autoantibody measurements by traditional methods.
Skip Nav Destination
Article navigation
Original Articles|
September 01 1989
Revelation of Specificity of 64K Autoantibodies in IDDM Serums by High-Resolution 2-D Gel Electrophoresis: Unambiguous Identification of 64K Target Antigen
Steinunn Bækkeskov;
Steinunn Bækkeskov
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Garth Warnock;
Garth Warnock
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Michael Christie;
Michael Christie
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Ray V Rajotte;
Ray V Rajotte
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Peter Mose Larsen;
Peter Mose Larsen
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Stephen Fey
Stephen Fey
Hagedorn Research Laboratory, Gentofte, Denmark; Surgical Medical Research Institute, University of Alberta, Edmonton, Canada; and the Departments of Medical Microbiology and Human Genetics, Århus University
Århus, Denmark
Search for other works by this author on:
Address correspondence and reprint requests to Steinunn Bækkeskov, Hagedorn Research Laboratory, Niels Steensensvej 6, DK-2820 Gentofte, Denmark.
Diabetes 1989;38(9):1133–1141
Article history
Received:
November 23 1988
Revision Received:
April 10 1989
Accepted:
April 10 1989
PubMed:
2670643
Citation
Steinunn Bækkeskov, Garth Warnock, Michael Christie, Ray V Rajotte, Peter Mose Larsen, Stephen Fey; Revelation of Specificity of 64K Autoantibodies in IDDM Serums by High-Resolution 2-D Gel Electrophoresis: Unambiguous Identification of 64K Target Antigen. Diabetes 1 September 1989; 38 (9): 1133–1141. https://doi.org/10.2337/diab.38.9.1133
Download citation file:
43
Views